Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
1.330
+0.050 (3.91%)
Nov 4, 2026, 4:00 PM EST - Market closed
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Silo Pharma the 42,942nd largest employer in the world and 6,990th in the United States.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$18,026
Profits / Employee
-$1,490,638
Market Cap
2.11M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| PMGC Holdings | 34 |
| Enlivex | 34 |
| Curis | 24 |
| BioRestorative Therapies | 14 |
| Genprex | 13 |
| Revelation Biosciences | 9 |
| Kairos Pharma | 4 |
SILO News
- 5 weeks ago - Silo Pharma’s QwikAgents expands AI agent platform with Nvidia model support - TheFly
- 5 weeks ago - Silo Pharma's QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility - GlobeNewsWire
- 6 weeks ago - Silo Pharma receives U.S. patent allowance for SPC-15 PTSD treatment - TheFly
- 6 weeks ago - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio - GlobeNewsWire
- 1 month ago - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - GlobeNewsWire
- 2 months ago - Silo Pharma receives notice of allowance from CIPO for PTSD treatment - TheFly
- 2 months ago - Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - GlobeNewsWire
- 2 months ago - Silo Pharma granted European patent covering PTSD therapy - TheFly